International Journal of Surgical Oncology / 2012 / Article / Fig 2

Clinical Study

Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II Trial

Figure 2

Mean tumour size in time in patients responding to neoadjuvant imatinib treated for 12 months ( ).
761576.fig.002